title: The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.
abstract: Histopathology of endomyocardial biopsies (EMB) is the standard rejection surveillance for heart transplants. However, ISHLT consensus criteria for interpreting biopsies are arbitrarily defined. Gene expression offers an independent re-evaluation of existing diagnostic systems. We performed histologic and microarray analysis on 105 EMB from 45 heart allograft recipients. Histologic lesions, diagnosis and transcripts were compared to one another, time posttransplantation, indication for biopsy and left ventricular ejection fraction (LVEF). Histologic lesions presented in two groups: myocyte-interstitial and microcirculation lesions. Expression of transcript sets reflecting T cell and macrophage infiltration, and γ-interferon effects correlated strongly with each other and with transcripts indicating tissue/myocardium injury. This molecular phenotype correlated with Quilty (p < 0.005), microcirculation lesions (p < 0.05) and decreased LVEF (p < 0.007), but not with the histologic diagnosis of rejection. In multivariate analysis, LVEF was associated (p < 0.03) with γ-interferon inducible transcripts, time posttransplantation, ischemic injury and clinically indicated biopsies, but not the diagnosis of rejection. The results indicate that (a) the current ISHLT system for diagnosing rejection does not reflect the molecular phenotype in EMB and lacks clinical relevance; (b) the interpretation of Quilty lesions has to be revisited; (c) the assessment of molecules in heart biopsy can guide improvements of current diagnostics.
authors.affiliation: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Mengel
authors.forename: B
authors.initials: B
authors.lastname: Sis
authors.forename: D
authors.initials: D
authors.lastname: Kim
authors.forename: J
authors.initials: J
authors.lastname: Chang
authors.forename: K S
authors.initials: KS
authors.lastname: Famulski
authors.forename: L G
authors.initials: LG
authors.lastname: Hidalgo
authors.forename: G
authors.initials: G
authors.lastname: Einecke
authors.forename: D G
authors.initials: DG
authors.lastname: de Freitas
authors.forename: W
authors.initials: W
authors.lastname: Tymchak
authors.forename: J
authors.initials: J
authors.lastname: Burton
authors.forename: P F
authors.initials: PF
authors.lastname: Halloran
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D003935:Diagnostic Techniques, Cardiovascular / Q000592:standards; D004699:Endocardium / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis / Q000517:prevention & control; D006321:Heart / Q000503:physiopathology; D016027:Heart Transplantation / Q000473:pathology*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D008297:Male; D046228:Microarray Analysis; D008833:Microcirculation; D008875:Middle Aged; D015999:Multivariate Analysis; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology*; D010641:Phenotype; D013318:Stroke Volume; D014019:Tissue Donors; D014158:Transcription, Genetic / Q000187:drug effects; D014184:Transplantation, Homologous / Q000473:pathology; D014652:Vascular Diseases / Q000378:metabolism; D016277:Ventricular Function, Left; D055815:Young Adult
chemical_list: D007371:Interferon-gamma